B7-H3 (also known as CD276) belongs to a family of immune modulators (known as the B7 family) that includes PD-L1 (or B7-H1), and has been associated tumor immunosuppression and decreased survival of cancer patients [62]. This evidence concerns the gene CD276 and cancer.